Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-25T05:34:49.756Z Has data issue: false hasContentIssue false

The Self-Assessment of Resilience and Anxiety: Psychometric Properties

Published online by Cambridge University Press:  07 November 2014

Abstract

This report describes the psychometric properties of the Self-Assessment of Resilience and Anxiety (SARA) scale within the context of a study of kava for generalized anxiety. This eight-item, patient-rated scale includes questions designed to measure calmness, mental clarity, confidence, physical well being, sociability, and resilience. The SARA scale was administered during a clinical trial of kava versus placebo in 38 subjects diagnosed with generalized anxiety disorder (GAD). Validation of the SARA scale was assessed against the Hamilton Rating Scale for Anxiety, Hospital Anxiety and Depression Scale, Penn State Worry Questionnaire, Sheehan Disability Scale, Arizona Sexual Experience scale, and Clinical Global Impression of Illness Improvement scale. Good test-retest reliability, internal consistency, convergent validity, and sensitivity to treatment were identified, and factor analyses revealed a three-factor internal structure. The SARA scale was responsive to symptom change over time and correlated with comparable GAD symptom measures. The SARA scale demonstrates solid psychometric properties and may serve as a reliable and valid measure in the use of kava or related medicinal herbs.

Type
Original Research
Copyright
Copyright © Cambridge University Press 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Pittler, MH, Ernst, E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol. 2000;20:8489.CrossRefGoogle ScholarPubMed
2. Lewin, L. Phantastica: A Classic Survey on the Use and Abuse of Mind-Altering Plants. Rochester, VT: Park Street Press; 1998.Google Scholar
3. Gregory, RJ. Vanuatu: kava and the conflicts of colonialism. In: Edwards, G, Arif, A, Jaffe, J, eds. Drug Use and Misuse: Cultural Perspectives. London, England: Croom Helm; 1983.Google Scholar
4. Murray, MT. Kava. In: The Healing Power of Herbs. Rocklin, CA: Prima Publishing; 1995:210220.Google Scholar
5. Hamilton, M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:5055.CrossRefGoogle ScholarPubMed
6. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
7. Sheehan, DV, Lecrabier, Y, Sheehan, KH, et al. Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R, Dunbar, GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):2233.Google ScholarPubMed
8. Zigmond, AS, Snaith, RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361370.CrossRefGoogle ScholarPubMed
9. Meyer, TJ, Miller, ML, Metzger, RL, Borkovec, TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28:487495.CrossRefGoogle ScholarPubMed
10. Sheehan, DV, Raj, AB, Sheehan, KH, Soto, S. Is buspirone effective for panic disorder? J Clin Psychopharmacol. 1990;10:311.CrossRefGoogle ScholarPubMed
11. McGahuey, CA, Gelenberg, AJ, Laukes, CA, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26:2540.Google ScholarPubMed